{"id":"https://openalex.org/W3041387530","doi":"https://doi.org/10.3390/inorganics8070042","title":"In Vitro Evaluation of a Peptide-Mesoporous Silica Nanoparticle Drug Release System against HIV-1","display_name":"In Vitro Evaluation of a Peptide-Mesoporous Silica Nanoparticle Drug Release System against HIV-1","publication_year":2020,"publication_date":"2020-07-13","ids":{"openalex":"https://openalex.org/W3041387530","doi":"https://doi.org/10.3390/inorganics8070042","mag":"3041387530"},"language":"en","primary_location":{"id":"doi:10.3390/inorganics8070042","doi":"https://doi.org/10.3390/inorganics8070042","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/inorganics8070042","pdf_url":"https://www.mdpi.com/2304-6740/8/7/42/pdf","source":{"id":"https://openalex.org/S2737417813","display_name":"Inorganics","issn_l":"2304-6740","issn":["2304-6740"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inorganics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/2304-6740/8/7/42/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Katharina Braun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Katharina Braun","raw_affiliation_strings":["Inorganic Chemistry II, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inorganic Chemistry II, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany","institution_ids":["https://openalex.org/I196349391"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044838008","display_name":"Christina Martina St\u00fcrzel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155144","display_name":"University Hospital Ulm","ror":"https://ror.org/05emabm63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155144"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christina M. St\u00fcrzel","raw_affiliation_strings":["Institute of Molecular Virology, Ulm University Medical Centre, Meyerhofstra\u00dfe 1, 89081 Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Molecular Virology, Ulm University Medical Centre, Meyerhofstra\u00dfe 1, 89081 Ulm, Germany","institution_ids":["https://openalex.org/I4210155144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075006919","display_name":"Frank Kirchhoff","orcid":"https://orcid.org/0000-0002-7052-2360","observed_orcids":["https://orcid.org/0000-0002-7052-2360"]},"institutions":[{"id":"https://openalex.org/I4210155144","display_name":"University Hospital Ulm","ror":"https://ror.org/05emabm63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155144"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Frank Kirchhoff","raw_affiliation_strings":["Institute of Molecular Virology, Ulm University Medical Centre, Meyerhofstra\u00dfe 1, 89081 Ulm, Germany"],"raw_orcid":"https://orcid.org/0000-0002-7052-2360","affiliations":[{"raw_affiliation_string":"Institute of Molecular Virology, Ulm University Medical Centre, Meyerhofstra\u00dfe 1, 89081 Ulm, Germany","institution_ids":["https://openalex.org/I4210155144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025957327","display_name":"Mika Lind\u00e9n","orcid":"https://orcid.org/0000-0003-1736-0638","observed_orcids":["https://orcid.org/0000-0003-1736-0638"]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Mika Lind\u00e9n","raw_affiliation_strings":["Inorganic Chemistry II, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inorganic Chemistry II, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany","institution_ids":["https://openalex.org/I196349391"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5025957327"],"corresponding_institution_ids":["https://openalex.org/I196349391"],"apc_list":{"value":1000,"currency":"CHF","value_usd":1056},"apc_paid":{"value":1000,"currency":"CHF","value_usd":1056},"fwci":0.2449,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.33369892,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"8","issue":"7","first_page":"42","last_page":"42"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10735","display_name":"Mesoporous Materials and Catalysis","score":0.007699999958276749,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-entry-inhibitors","display_name":"HIV-1 entry inhibitors","score":0.7990000247955322},{"id":"https://openalex.org/keywords/mesoporous-silica-nanoparticles","display_name":"mesoporous silica nanoparticles","score":0.8730000257492065},{"id":"https://openalex.org/keywords/peptide-delivery","display_name":"peptide delivery","score":0.8989999890327454},{"id":"https://openalex.org/keywords/controlled-drug-release","display_name":"controlled drug release","score":0.6700000166893005},{"id":"https://openalex.org/keywords/peptide-loading","display_name":"peptide loading","score":0.7839999794960022},{"id":"https://openalex.org/keywords/adsorption-isotherms","display_name":"adsorption isotherms","score":0.828000009059906},{"id":"https://openalex.org/keywords/serum-protein-adsorption","display_name":"serum protein adsorption","score":0.800000011920929},{"id":"https://openalex.org/keywords/silica-dissolution","display_name":"silica dissolution","score":0.6850000023841858},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.9620000123977661},{"id":"https://openalex.org/keywords/tzm-bl-cells","display_name":"TZM-bl cells","score":0.7829999923706055},{"id":"https://openalex.org/keywords/local-drug-release","display_name":"local drug release","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.8056098222732544},{"id":"https://openalex.org/C2777496208","wikidata":"https://www.wikidata.org/wiki/Q17156473","display_name":"Mesoporous silica","level":4,"score":0.6163291335105896},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.5679901838302612},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.5418269634246826},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.539052426815033},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4969351589679718},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4541175365447998},{"id":"https://openalex.org/C150394285","wikidata":"https://www.wikidata.org/wiki/Q180254","display_name":"Adsorption","level":2,"score":0.42518889904022217},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.3602760434150696},{"id":"https://openalex.org/C82776694","wikidata":"https://www.wikidata.org/wiki/Q380049","display_name":"Mesoporous material","level":3,"score":0.3307717740535736},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.2483418881893158},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.20195966958999634},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17912507057189941},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.12593066692352295},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10654643177986145},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3390/inorganics8070042","doi":"https://doi.org/10.3390/inorganics8070042","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/inorganics8070042","pdf_url":"https://www.mdpi.com/2304-6740/8/7/42/pdf","source":{"id":"https://openalex.org/S2737417813","display_name":"Inorganics","issn_l":"2304-6740","issn":["2304-6740"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inorganics","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:05701690402d436198caacbf4dfc5450","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/05701690402d436198caacbf4dfc5450","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Inorganics, Vol 8, Iss 7, p 42 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/inorganics8070042","doi":"https://doi.org/10.3390/inorganics8070042","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/inorganics8070042","pdf_url":"https://www.mdpi.com/2304-6740/8/7/42/pdf","source":{"id":"https://openalex.org/S2737417813","display_name":"Inorganics","issn_l":"2304-6740","issn":["2304-6740"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inorganics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1195029094","display_name":null,"funder_award_id":"CRC-1279","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G1243669781","display_name":"Innovative Nanoformulation of Antimicrobial Peptides to Treat Bacterial Infectious Diseases","funder_award_id":"604182","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G3207356259","display_name":null,"funder_award_id":"2007\u20132013","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G393177772","display_name":null,"funder_award_id":"FP7 2007-2013","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G4760961572","display_name":null,"funder_award_id":"FP7/2007\u20132013","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G5702163051","display_name":null,"funder_award_id":"FP7/2007","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G8220089410","display_name":null,"funder_award_id":"604182","funder_id":"https://openalex.org/F4320333065","funder_display_name":"Seventh Framework Programme"}],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"},{"id":"https://openalex.org/F4320333065","display_name":"Seventh Framework Programme","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3041387530.pdf","grobid_xml":"https://content.openalex.org/works/W3041387530.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W81596332","https://openalex.org/W1969711244","https://openalex.org/W1983800253","https://openalex.org/W2000330915","https://openalex.org/W2020687628","https://openalex.org/W2026361605","https://openalex.org/W2054219881","https://openalex.org/W2059898245","https://openalex.org/W2073985947","https://openalex.org/W2086232429","https://openalex.org/W2126255146","https://openalex.org/W2127355586","https://openalex.org/W2146478787","https://openalex.org/W2153099927","https://openalex.org/W2209699590","https://openalex.org/W2317879149","https://openalex.org/W2336461887","https://openalex.org/W2346680648","https://openalex.org/W2552080741","https://openalex.org/W2750861100","https://openalex.org/W2809515169","https://openalex.org/W2889619363","https://openalex.org/W2915574559","https://openalex.org/W2943108585","https://openalex.org/W2943824126","https://openalex.org/W2967396404","https://openalex.org/W2981285269","https://openalex.org/W2987932370"],"related_works":["https://openalex.org/W3206962907","https://openalex.org/W3038103356","https://openalex.org/W3201800091","https://openalex.org/W2346734892","https://openalex.org/W2922080529","https://openalex.org/W2464441226","https://openalex.org/W3021879444","https://openalex.org/W3013356872","https://openalex.org/W2927890113","https://openalex.org/W2772873962"],"abstract_inverted_index":{"It":[0],"has":[1],"been":[2],"shown":[3],"that":[4,66,137,191,202,229,310],"the":[5,10,16,51,98,104,110,122,150,164,185,196,212,216,220,252,259,265,274,282,306,346],"optimized":[6],"VIR-576":[7,56,175,182,194,204],"derivative":[8],"of":[9,31,55,72,95,153,172,192,222,248,254,284,295,351],"natural":[11],"HIV-1":[12,162],"entry":[13],"inhibitor":[14],"targeting":[15],"viral":[17],"gp41":[18],"fusion":[19],"peptide":[20,33,70,96,146,308],"is":[21,263],"safe":[22],"and":[23,36,53,103,163,174,214],"effective":[24],"in":[25,62,207,219,281,287,296,300,349],"infected":[26],"individuals.":[27],"However,":[28,126],"high":[29,69,307,342],"doses":[30],"this":[32],"were":[34,159,167],"required,":[35],"stability,":[37],"as":[38,40,107,169,243,245,316],"well":[39,244],"delivery,":[41],"must":[42],"be":[43,77,115,312,337],"improved":[44],"for":[45,181,268,276,291,323],"clinical":[46],"application.":[47],"Here,":[48],"we":[49],"examined":[50],"loading":[52,71,348],"release":[54,93,129,217,279,325],"into/from":[57],"mesoporous":[58],"silica":[59,255,261],"nanoparticles":[60],"(MSNs)":[61],"vitro.":[63],"We":[64],"found":[65],"a":[67,127,142,170,292,319,333],"moderately":[68],"11.5":[73],"wt":[74],"%":[75],"could":[76,113],"achieved":[78,313],"by":[79,109],"adsorption":[80,111],"from":[81,184,211],"PBS":[82],"buffer":[83,100],"(pH":[84],"7.2),":[85],"i.e.,":[86],"under":[87,231,256],"mild,":[88],"fully":[89],"peptide-compatible":[90],"conditions.":[91,233,302],"The":[92,177],"rate":[94,218],"into":[97],"same":[99],"was":[101,130,187,205,225],"slow":[102],"equilibrium":[105],"concentration":[106,262],"indicated":[108],"isotherm":[112],"not":[114],"reached":[116],"even":[117],"within":[118],"50":[119],"h":[120,198],"at":[121,132,195],"particle":[123,134,139],"concentrations":[124],"studied.":[125],"faster":[128],"observed":[131,180,230],"lower":[133],"concentrations,":[135],"indicating":[136,201],"partial":[138],"dissolution":[140],"had":[141],"positive":[143],"influence":[144],"on":[145,239,251],"release.":[147],"To":[148],"determine":[149],"antiviral":[151],"activity":[152,179],"VIR-576-loaded":[154],"MSNs,":[155,213],"TZM-bl":[156],"indicator":[157],"cells":[158],"exposed":[160],"to":[161,190,289,299,305,340],"infection":[165],"rates":[166],"followed":[168],"function":[171],"time":[173,199],"concentration.":[176],"inhibitory":[178],"released":[183,206],"MSNs":[186,315],"virtually":[188],"identical":[189],"free":[193],"48":[197],"point,":[200],"(a)":[203],"an":[208],"active":[209],"form":[210],"(b)":[215],"presence":[221,283],"serum":[223,249,285],"proteins":[224,250],"clearly":[226],"higher":[227,334],"than":[228],"protein-free":[232],"These":[234],"observations":[235],"are":[236],"discussed":[237],"based":[238],"competitive":[240],"peptide/protein":[241],"adsorption,":[242],"potential":[246],"influences":[247],"dissolution-reprecipitation":[253],"conditions":[257],"where":[258],"total":[260],"above":[264],"saturation":[266],"level":[267],"dissolved":[269],"silica.":[270],"Our":[271],"results":[272],"highlight":[273],"need":[275],"studying":[277],"drug":[278,347],"kinetics":[280],"proteins,":[286],"order":[288],"allow":[290],"better":[293],"extrapolation":[294],"vitro":[297],"data":[298],"vivo":[301],"Furthermore,":[303],"due":[304,339],"loadings":[309],"can":[311],"using":[314],"carriers,":[317],"such":[318],"formulation":[320],"appears":[321],"promising":[322],"local":[324],"applications.":[326],"For":[327],"systemic":[328],"administration,":[329],"however,":[330],"peptides":[331],"with":[332],"potency":[335],"would":[336],"needed,":[338],"their":[341],"molar":[343],"masses":[344],"limiting":[345],"terms":[350],"moles":[352],"per":[353],"gram":[354],"carrier.":[355]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2020-07-16T00:00:00"}